JWDx is Taiwan's first and leading B2B precision medicine testing platform driven by the sharing ecosystem, co-founded by Bio-Check and Taipei Medical University.
Core Principles & Technology
Philosophy: Breaks down institutional silos through resource sharing to maximize medical efficiency.
Mechanism: Integrates multiple medical-center-level accredited labs (LDTs, CAP, ISO 15189).
Solution: Overcomes single-institution bottlenecks caused by high equipment costs and a shortage of specialized talent.
Key Features & Advantages
Seamless Workflow: Provides a one-stop digital ecosystem featuring automated specimen logistics and smart reporting. Diverse Portfolio: Offers over 100 unique, premium, and advanced testing items on a single platform.
Strict Quality Control: Ensures clinical-grade accuracy through rigorous laboratory verification mechanisms.
Applications & Healthcare Uses
Covering the entire life cycle, the platform empowers both wellness management and clinical decisions:
Hereditary & Prenatal Genomics: Advanced genetic screenings for premarital and prenatal care. Preventive Medicine: Early screening tools, including WES and WGS disease risk tests, exclusive IMR blood tests for dementia risk and AI gut microbiome analysis for personalized wellness. Precision Oncology: Comprehensive NGS analysis and targeted drug selection to help clinicians tailor optimal treatment plans and minimize side effects.
Since this service is not a physical product, data regarding physical product validation during the development and mass production stages is not included.
All testing items provided comply with laboratory accreditation and satisfy the rigorous quality requirements of medical institutions.
Furthermore, certain testing services have obtained Taiwan Food and Drug Administration (TFDA) IVD clearance, EU CE-IVD certification, and have been validated through joint clinical trials across Europe, the United States, and Taiwan.
Since this service is not the manufacturing of a traditional, physical industrial product, it does not include standard manufacturing process quality inspection steps.
This service is designed for use within healthcare institution systems and adheres strictly to their institutional quality requirements. To support hospital quality audits and ensure testing stability and clinical benefit, a dedicated team systematically manages and provides various laboratory quality system certificates—such as College of American Pathologists (CAP) accreditation, TAF ISO 15189 medical laboratory accreditation, or Taiwan Society of Pathology molecular pathology accreditation—along with proficiency testing (PT) documentations.
Medical & Regulatory Risk Control
Mitigating Referral Risks: By adopting a B2B model, testing items undergo hospital quality audits and are integrated into internal systems. Relying on routine hospital procedures effectively reduces medical referral risks for physicians and institutions.
Regulatory Compliance: We established a "collaborative submission with key hospitals" mechanism to accelerate health department approvals for self-pay items. Once approved (e.g., 22 items cleared by Taipei City), services are safely expanded to other hospitals to ensure strict compliance.
2. IP & Authorization Security
Legal Authorization: All testing services are backed by formal contracts with top-tier labs (e.g., Centogene, Chi Mei Medical Center, TMUH), ensuring legal technology sources and preventing intellectual property infringement.
Asset Protection: Promotional and educational materials are systematically managed with proper copyrights. The official website utilizes copy-restriction features to prevent data extraction by competitors.
3. Personnel & Data Security
NDAs: Employees sign Non-Disclosure Agreements upon hiring, assigning all job-related intellectual property to the company and preventing rights infringement.
Tiered Access Control: Internal files and sensitive data (e.g., pricing, client info, performance reports) are strictly managed through a role-based tiered access system to effectively prevent commercial secret leaks.
As a B2B testing sharing platform, JW DX's post-market management prioritizes cloud system maintenance, source quality prevention, and clinical crisis response over physical manufacturing CAPA:
1. Software & Security Maintenance
Routine Upgrades: IT maintenance is an ongoing fixed cost. Dedicated staff manage software upgrades, operations, and database security.
Tiered Control: To protect privacy and prevent leaks, internal files undergo strict role-based tiered management. The website uses copy-restrictions to secure core data.
2. Quality Anomaly Prevention
Mandatory Accreditation: To avoid medical risks, partner labs must hold CAP or TAF ISO 15189 accreditations and pass hospital audits, blocking anomalies at the source.
Traceability: All product, QC, and report details are systematically documented. This ensures immediate traceability and auditing if anomalies occur.
3. Clinical Crisis Response
Risk Sharing: The B2B model integrates reports into hospital systems for attending physicians to explain. Using routine procedures relieves physicians from the solitary referral risks of B2C models.
Expert Advisory: For complex cases or report disputes, a PhD-level genetics team collaborates with Taipei Medical University's advisory board to provide physicians with immediate, expert clinical support.
